Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardiff Oncology (CRDF) Other Operating Expenses (2016 - 2018)

Historic Other Operating Expenses for Cardiff Oncology (CRDF) over the last 7 years, with Q3 2018 value amounting to $26677.0.

  • Cardiff Oncology's Other Operating Expenses fell 9436.24% to $26677.0 in Q3 2018 from the same period last year, while for Jun 2019 it was $26677.0, marking a year-over-year decrease of 9817.0%. This contributed to the annual value of -$28244.0 for FY2020, which is 152790.7% down from last year.
  • Latest data reveals that Cardiff Oncology reported Other Operating Expenses of $26677.0 as of Q3 2018, which was down 9436.24% from $204436.0 recorded in Q2 2018.
  • Cardiff Oncology's Other Operating Expenses' 5-year high stood at $4.6 million during Q4 2014, with a 5-year trough of $26677.0 in Q3 2018.
  • In the last 5 years, Cardiff Oncology's Other Operating Expenses had a median value of $616426.0 in 2017 and averaged $1.5 million.
  • Per our database at Business Quant, Cardiff Oncology's Other Operating Expenses skyrocketed by 26506.44% in 2015 and then plummeted by 9436.24% in 2018.
  • Over the past 5 years, Cardiff Oncology's Other Operating Expenses (Quarter) stood at $4.6 million in 2014, then tumbled by 53.21% to $2.1 million in 2015, then skyrocketed by 39.79% to $3.0 million in 2016, then plummeted by 86.13% to $413764.0 in 2017, then tumbled by 93.55% to $26677.0 in 2018.
  • Its Other Operating Expenses stands at $26677.0 for Q3 2018, versus $204436.0 for Q2 2018 and $366344.0 for Q1 2018.